Literature DB >> 16593727

In vitro transcription of infectious RNAs from full-length cDNAs of tobacco mosaic virus.

T Meshi1, M Ishikawa, F Motoyoshi, K Semba, Y Okada.   

Abstract

We have cloned full-length double-stranded cDNAs of tobacco mosaic virus (TMV) (tomato strain L) RNA into a transcription vector, pPM1, which facilitates the correct transcription initiation from the first nucleotide of the inserted double-stranded cDNA, corresponding to the 5' end of TMV RNA. When plasmid DNA is linearized at a unique restriction site (Mlu I) introduced just downstream of the double-stranded cDNA insert and used as a template for in vitro transcription by Escherichia coli RNA polymerase in the presence of m(7)GpppG, the transcribed RNAs are infectious for tobacco plants. A simple reconstitution procedure increases the infectivity >100 times. Unexpectedly, both the uncapped transcript and the transcript from the uncut plasmid DNA are also infectious, although their infectivities are very low. The progeny viruses multiplying in tobacco plants accurately reflect the cloned sequence. By the same method, we succeeded in the in vitro transcription of infectious RNA of attenuated strain L(11)A, which is phenotypically distinguishable from wild-type TMV on both tobacco and tomato plants.

Entities:  

Year:  1986        PMID: 16593727      PMCID: PMC323886          DOI: 10.1073/pnas.83.14.5043

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  The 5' end group of tobacco mosaic virus RNA is m7G5' ppp5' Gp.

Authors:  D Zimmern
Journal:  Nucleic Acids Res       Date:  1975-07       Impact factor: 16.971

3.  Importance of 5'-terminal blocking structure to stabilize mRNA in eukaryotic protein synthesis.

Authors:  K Shimotohno; Y Kodama; J Hashimoto; K I Miura
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

4.  Enzymatic removal of the 5'-terminal methylated blocked structure of tobacco mosaic virus RNA and its effects on infectivity and reconstitution with coat protein.

Authors:  T Ohno; Y Okada; K Shimotohno; K Miura; H Shinshi
Journal:  FEBS Lett       Date:  1976-08-15       Impact factor: 4.124

5.  Kinetics of biphasic reconstitution of tobacco mosaic virus in vitro.

Authors:  M Fukuda; T Ohno; Y Okada; Y Otsuki; I Takebe
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

6.  Direct chemical method for sequencing RNA.

Authors:  D A Peattie
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

7.  5'-Terminal structure and mRNA stability.

Authors:  Y Furuichi; A LaFiandra; A J Shatkin
Journal:  Nature       Date:  1977-03-17       Impact factor: 49.962

8.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.

Authors:  M J Casadaban; S N Cohen
Journal:  J Mol Biol       Date:  1980-04       Impact factor: 5.469

9.  Tobacco mosaic virus: model for structure and function of a simple virus.

Authors:  L Hirth; K E Richards
Journal:  Adv Virus Res       Date:  1981       Impact factor: 9.937

10.  Multicomponent RNA plant virus infection derived from cloned viral cDNA.

Authors:  P Ahlquist; R French; M Janda; L S Loesch-Fries
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

View more
  42 in total

1.  Phosphorylation and/or presence of serine 37 in the movement protein of tomato mosaic tobamovirus is essential for intracellular localization and stability in vivo.

Authors:  S Kawakami; H S Padgett; D Hosokawa; Y Okada; R N Beachy; Y Watanabe
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 2.  Tobacco mosaic virus. Pioneering research for a century.

Authors:  A N Creager; K B Scholthof; V Citovsky; H B Scholthof
Journal:  Plant Cell       Date:  1999-03       Impact factor: 11.277

Review 3.  Historical overview of research on the tobacco mosaic virus genome: genome organization, infectivity and gene manipulation.

Authors:  Y Okada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-03-29       Impact factor: 6.237

4.  In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA.

Authors:  K Yamanaka; N Ogasawara; H Yoshikawa; A Ishihama; K Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Complete nucleotide sequence and genome organization of hibiscus chlorotic ringspot virus, a new member of the genus Carmovirus: evidence for the presence and expression of two novel open reading frames.

Authors:  M Huang; D C Koh; L J Weng; M L Chang; Y K Yap; L Zhang; S M Wong
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Deletion analysis of the 5' untranslated leader sequence of tobacco mosaic virus RNA.

Authors:  N Takamatsu; Y Watanabe; T Iwasaki; T Shiba; T Meshi; Y Okada
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Complete replication in vitro of tobacco mosaic virus RNA by a template-dependent, membrane-bound RNA polymerase.

Authors:  T A Osman; K W Buck
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  Role of 3'-end sequences in infectivity of poliovirus transcripts made in vitro.

Authors:  P Sarnow
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

9.  Tomato mosaic virus replication protein suppresses virus-targeted posttranscriptional gene silencing.

Authors:  Kenji Kubota; Shinya Tsuda; Atsushi Tamai; Tetsuo Meshi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  In vitro mutagenesis of the putative replicase genes of tobacco mosaic virus.

Authors:  M Ishikawa; T Meshi; F Motoyoshi; N Takamatsu; Y Okada
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.